End Of Life Treatment For Patient With Terminal Cancer Case Study

PAGES
4
WORDS
1256
Cite

C.G. The history of C.G. is that he is a former smoker, 69-year-old male with cancer in the head and neck (a radical neck dissection was performed in 2012), which has recently metastasized in the liver and lungs, as indicated by PET scan which shows metabolic activity. The patient suffers from moderately-severe depression with a PHQ-9 score of 15 (Kroenke, Spitzer, Williams, 2001) and refuses anymore chemotherapy. He is at a point now where he wants to know his options for what remains of the rest of his life, indicating that he is not willing to undergo any further treatment for the his cancer or its spread.

The results of the physical show that C.G. suffers from hypertension, hyperlipidemia, stomatitis, anemia, and neutropenia. He is currently receiving 12.5 mg of Carvedilol daily plus 40 mg of Furosemide daily. His BP indicates that he has "isolated systolic hypertension" and it is likely that the treatment for and failure to stop the spread of his cancer has contributed to the stress that his body his under, which is registered in his mental and emotional fatigue and desire to cease all treatment for the cancer. The rest of the physical has not revealed any serious problems or defects other than the expected limited range of motion in the head/neck and Ronchi detected in the lungs.

The differential diagnosis suggests liver cancer, adjustment disorder, and chemotherapy side effects, but the primary diagnosis is metastatic cancer. The rationale for the primary diagnosis is the evidence of metabolic activity in the liver and lungs as well as in the neck, indicating that the cancer has indeed spread throughout the body (Berman, 2004). The rationale for the differential dx -- liver cancer -- is based on the same indications but ignores the possibility of the spread of the cancer from the neck (Berman, 2004)....

...

Nonetheless, the metabolic activity is indicative of the spread of the cancer from the neck and not merely an unrelated cancerous development (Berman, 2004). Also the likelihood of chemotherapy side affects is not dismissed as this is also very likely a possibility; however, it is not a sufficient diagnosis or explanation for the spread of metabolic activity in the liver and lungs.
Secondary diagnosis includes hypertension, somatitis, Anemia, Neutropenia, Hyperlipidermia, effects of tobacco use, and right head and neck cancer. The rationale for these diagnoses are found in the effects of unhealthy lifestyle (smoking, diet) as well as age and stress factors linked to the radiation therapy, which accounts for the Neutropenia too (Davis, Squier, Lilly, 1998).

At this point, because the patient is refusing further treatment, the complete treatment plan is focusing on quality of life and suggests preparing the patient and the family for the coming end of life for C. G. At this time care should be taken to consider how best to utilize the remaining time and to provide comfort and consideration to the patient and family members who will be with him. Care giver information should be secured from hospice as an alternative if necessary, for help with medications to ease the pain of the patient as…

Sources Used in Documents:

References

Aragon-Ching, J., Zujewski, J. (2007) CNS metastasis: an old problem in a new guise.

Clinical Cancer Research, 13(6): 1644-1647.

Berman, J. (2004). Tumor classification: molecular analysis meets Aristotle. BMC

Cancer, 4(1): 10.


Cite this Document:

"End Of Life Treatment For Patient With Terminal Cancer" (2015, October 16) Retrieved April 26, 2024, from
https://www.paperdue.com/essay/end-of-life-treatment-for-patient-with-terminal-2155604

"End Of Life Treatment For Patient With Terminal Cancer" 16 October 2015. Web.26 April. 2024. <
https://www.paperdue.com/essay/end-of-life-treatment-for-patient-with-terminal-2155604>

"End Of Life Treatment For Patient With Terminal Cancer", 16 October 2015, Accessed.26 April. 2024,
https://www.paperdue.com/essay/end-of-life-treatment-for-patient-with-terminal-2155604

Related Documents

nursing research findings into clinical practice. Nociceptive Pain at the end of life Conduct a Medline/PubMed & CINAHL search to identify 2 (two) PRIMARY SOURCE research articles that were published within the last 5 years that are not cited in the text Oxford Textbook of Palliative Nursing by Ferrell & Coyles chapter 6. McMillan and Small (2007) conducted research in order to test whether the COPE intervention would help caregivers better manage

" (2003) It is reported in the work of Morrow (2009) that prior to palliative sedation being considered the team of people caring for the patient or the palliative care team "…will look at many possible options to help relieve suffering, such as aggressive symptom management (using any and all medications and treatments that may help) and mental support to help with emotional concerns. The goal is to make the patient

Life Dilemmas in Nursing End of life End of Life Dilemmas in Nursing: Issues with Euthanasia and How to Approach Them A friend of mine had the unfortunate experience of having to make a decision about withdrawing health care from his terminally ill wife. Even without revealing too much detail about the case the description of this incident is rather disturbing. His wife had been treated for breast cancer, but several months

Introduction When a family has to decide how much is too much, as Plakovic (2016) puts it during end-of-life care, there is a clear ethical dilemma that crops up for family members and care providers. That dilemma is related to the issue of how to approach end-of-life treatment. For instance, some individual have strict preferences when it comes to whether or not they want to be resuscitated or kept alive by

One of the ways cancer has changed Rollin's outlook on life is how she is "less worried about what people think of me, both professionally and socially." Her self-consciousness is gone because to worry about what other people think is so trivial compared with the reality of mortality. Rollins also claims, "I am less concerned about where my career is going." Her career is only a small part of who

Living With Incurable Cancer at the End of Life-Patients' Perceptions on Quality of Life Johansson, Christina Melin RN, Phd-student; Axelsson, Bertil MD, PhD; Danielson, Ella RN, PhD This article is either a qualitative or a quantitative research study. Identify which, and then complete the table below where applicable. Write no more than three sentences in each cell of the table. The study may not contain all of the elements listed, or the